What We're Reading: Reviewing Gene Therapies; States Assist With Health Premiums; Healthcare Interpreters
The FDA will start to review gene therapy experiments and products the same as other treatments and drugs; Alaska and Minnesota have become models for other states looking to curb health insurance premium increases with reinsurance programs; patients with limited English proficiency often have to rely on family members and friends to interpret for them, which can have serious consequences.
Special Regulations for Gene Therapies Removed
The FDA will start to review gene therapy experiments and products the same as other treatments and drugs.
States Invest in Reinsurance Programs to Lower Health Insurance Premiums
Alaska and Minnesota have become models for other states looking to curb health insurance premium increases. Both states have launched reinsurance programs that help pay the cost of people with high medical bills, which allows insurers to lower premiums overall,
Medical Interpreters Needed to Translate for Immigrant Patients
While the law requires facilities that offer medical services and receive federal funds to provide access for patients to make informed decisions, such as through qualified interpreters, patients with limited English proficiency often have to rely on family members and friends to interpret for them.
Newsletter
Stay at the forefront of cutting-edge science with CGT—your direct line to expert insights, breakthrough data, and real-time coverage of the latest advancements in cell and gene therapy.
Related Articles
- Around the Helix: Cell and Gene Therapy Company Updates – September 17, 2025
September 17th 2025
- ImmunoLogic, Episode 6: "The Future of Personalized Cancer Vaccines”
September 15th 2025
- Top News in Lymphoma Cell Therapy for World Lymphoma Awareness Day 2025
September 15th 2025